These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11641779)

  • 1. Overexpression of an mRNA-binding protein in human colorectal cancer.
    Ross J; Lemm I; Berberet B
    Oncogene; 2001 Oct; 20(45):6544-50. PubMed ID: 11641779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
    Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
    J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
    Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
    Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer.
    Dimitriadis E; Trangas T; Milatos S; Foukas PG; Gioulbasanis I; Courtis N; Nielsen FC; Pandis N; Dafni U; Bardi G; Ioannidis P
    Int J Cancer; 2007 Aug; 121(3):486-94. PubMed ID: 17415713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells.
    Fakhraldeen SA; Clark RJ; Roopra A; Chin EN; Huang W; Castorino J; Wisinski KB; Kim T; Spiegelman VS; Alexander CM
    J Biol Chem; 2015 May; 290(21):13386-400. PubMed ID: 25861986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides.
    Coulis CM; Lee C; Nardone V; Prokipcak RD
    Mol Pharmacol; 2000 Mar; 57(3):485-94. PubMed ID: 10692488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary tumor induction in transgenic mice expressing an RNA-binding protein.
    Tessier CR; Doyle GA; Clark BA; Pitot HC; Ross J
    Cancer Res; 2004 Jan; 64(1):209-14. PubMed ID: 14729626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
    Ioannidis P; Mahaira LG; Perez SA; Gritzapis AD; Sotiropoulou PA; Kavalakis GJ; Antsaklis AI; Baxevanis CN; Papamichail M
    J Biol Chem; 2005 May; 280(20):20086-93. PubMed ID: 15769738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
    Mehmood K; Akhtar D; Mackedenski S; Wang C; Lee CH
    Mol Pharmacol; 2016 Jun; 89(6):606-17. PubMed ID: 27036131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
    Sparanese D; Lee CH
    Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors.
    Ioannidis P; Kottaridi C; Dimitriadis E; Courtis N; Mahaira L; Talieri M; Giannopoulos A; Iliadis K; Papaioannou D; Nasioulas G; Trangas T
    Cancer Lett; 2004 Jun; 209(2):245-50. PubMed ID: 15159028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of RanBP7 mRNA in colorectal carcinoma are associated with increased proliferation and are similar to the transcription pattern of the proto-oncogene c-myc.
    Li SR; Gyselman VG; Dorudi S; Bustin SA
    Biochem Biophys Res Commun; 2000 May; 271(2):537-43. PubMed ID: 10799331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant.
    Lemm I; Ross J
    Mol Cell Biol; 2002 Jun; 22(12):3959-69. PubMed ID: 12024010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
    Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
    Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
    Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
    Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors.
    Ioannidis P; Trangas T; Dimitriadis E; Samiotaki M; Kyriazoglou I; Tsiapalis CM; Kittas C; Agnantis N; Nielsen FC; Nielsen J; Christiansen J; Pandis N
    Int J Cancer; 2001 Nov; 94(4):480-4. PubMed ID: 11745432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein.
    Doyle GA; Bourdeau-Heller JM; Coulthard S; Meisner LF; Ross J
    Cancer Res; 2000 Jun; 60(11):2756-9. PubMed ID: 10850408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
    Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
    Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.